• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT COBE 2991; COBE 2991 BLOOD CELL PROCESSING SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT COBE 2991; COBE 2991 BLOOD CELL PROCESSING SET Back to Search Results
Catalog Number 90819
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Hemolysis (1886)
Event Date 08/09/2015
Event Type  malfunction  
Manufacturer Narrative
Investigation: fluid used during the deglycing procedure were 150ml of 12% nacl, 1000ml of 1.6% nacl and 1000ml of 0.9% nacl with 0.2% dextrose.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that they observed hemolysis in a unit of red blood cells (rbcs) during the final cycle of a deglycing procedure.During the 6th cycle of the procedure, they determined that there was hemolysis using a haemonetics free hemoglobin visual comparator card.A plasma free hemoglobin test was not performed.The unit was discarded.There was not a transfusion recipient or patient involved at the time of the rbc unit processing, therefore no patient information is reasonably known at the time of the event.The disposable set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Investigation: a service call was placed and a machine was check out was performed.The device was operating as designed.The centrifuge speed was found to be out of tolerance and was adjusted back to the correct specification.The speed was reading around 2950 rpm when set at 3000 rpm.Terumo bct engineer stated that this would result in potential yield issues and would take the process longer to complete but it would not lead to hemolysis.A review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Root cause: a definitive root cause could not be determined.Possible causes for the hemolysis include but are not limited to storage or handling for the frozen rbc unit.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBE 2991
Type of Device
COBE 2991 BLOOD CELL PROCESSING SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer Contact
glenda o'neill
10810 w. collins ave
lakewood, CO 80215
3032314051
MDR Report Key5057311
MDR Text Key25887255
Report Number1722028-2015-00511
Device Sequence Number1
Product Code CAC
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K893962
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial
Report Date 08/11/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2016
Device Catalogue Number90819
Device Lot Number11W15004
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/11/2015
Initial Date FDA Received09/04/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/25/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-